Windtree Therapeutics Inc (WINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,787 | -20,291 | -39,208 | -67,636 | -32,566 |
| Depreciation Amortization | 181 | 3,140 | 19,977 | 45,212 | 168 |
| Income taxes - deferred | -210 | N/A | -1,367 | -9,987 | N/A |
| Accounts payable and accrued liabilities | 1,070 | 560 | -444 | -468 | -547 |
| Other Working Capital | 1,371 | 2,018 | -1,777 | -58 | -1,328 |
| Other Operating Activity | -16,027 | 1,136 | 3,367 | 9,273 | 8,958 |
| Operating Cash Flow | $-15,402 | $-13,437 | $-19,452 | $-23,664 | $-25,315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -15 | 197 | -279 | -291 |
| Investing Cash Flow | $-12 | $-15 | $197 | $-279 | $-291 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,791 | N/A | N/A | N/A | N/A |
| Debt Issued | 1,862 | N/A | N/A | 1,000 | 3,347 |
| Debt Repayment | -605 | -797 | -1,174 | -3,872 | -3,776 |
| Common Stock Issued | 4,120 | 11,637 | N/A | 27,390 | 20,387 |
| Dividend Paid | -657 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -778 | 755 | 4,253 | 4,843 | 0 |
| Financing Cash Flow | $12,733 | $11,595 | $3,079 | $29,361 | $19,958 |
| Beginning Cash Position | 4,469 | 6,326 | 22,502 | 17,084 | 22,732 |
| End Cash Position | 1,788 | 4,469 | 6,326 | 22,502 | 17,084 |
| Net Cash Flow | $-2,681 | $-1,857 | $-16,176 | $5,418 | $-5,648 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,402 | -13,437 | -19,452 | -23,664 | -25,315 |
| Capital Expenditure | -12 | -15 | -13 | -279 | -291 |
| Free Cash Flow | -15,414 | -13,452 | -19,465 | -23,943 | -25,606 |